Untillabs
1 known investors
Until develops reversible cryopreservation systems for human donor organs, translating cryobiology into engineered workflows across perfusion, cryoprotectants, cooling, rewarming, and organ-health assessment. The technology aims to prevent ice formation during vitrification and address the donor organ procurement and matching problem.